Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiovascular Diseases: From Basic Research to Clinical Application-3rd Edition.

Life (Basel, Switzerland)·2026
Same author

Complex CTO Revascularization in Patients with Ischemic Heart Failure and Reduced Ejection Fraction: An Illustrative Case Series.

Journal of clinical medicine·2026
Same author

Multi-Kingdom Synergy of <i>Perilla frutescens</i>-Derived Effector Vesicles and Postbiotics: A Triple-Action Strategy for Atopic Dermatitis.

Life (Basel, Switzerland)·2026
Same author

The Role of Phytocompounds and the Physiological Response of the Skin in Common Dermatological Conditions: A Narrative Review and Bibliometric Analysis of Trends.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

Discordance Between Conventional Ultrasound and Transient Elastography in Hepatic Steatosis Assessment: Clinical Factors Associated with Discrepant Findings.

Diagnostics (Basel, Switzerland)·2026
Same author

The Evolution of the Mental Health-Acute Coronary Syndrome Intersection: A 50-Year Bibliometric Mapping and Changepoint Analysis (1975-2025).

Healthcare (Basel, Switzerland)·2026

Related Experiment Video

Updated: Jun 27, 2026

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

Non-ST-Elevation Myocardial Infarction: A Heterogeneous Syndrome with Evolving Management-A Narrative Review.

Silviu Raul Muste1, Elena Emilia Babes1,2, Cristiana Bustea1,3

  • 1Doctoral School of Biomedical Sciences, Faculty of Medicine and Pharmacy, University of Oradea, 410087 Oradea, Romania.

Biomedicines
|June 26, 2026
PubMed
Summary

Optimal revascularization strategies for non-ST-segment elevation myocardial infarction (NSTEMI) with multivessel coronary artery disease (MVD) are debated. Complete percutaneous coronary intervention (PCI) may reduce risks, but individualized decisions are crucial.

Keywords:
complete coronary revascularizationelderlymultivessel coronary artery diseasenon-ST-segment elevationpercutaneous coronary intervention

More Related Videos

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

Related Experiment Videos

Last Updated: Jun 27, 2026

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiovascular Medicine

Background:

  • Non-ST-segment elevation myocardial infarction (NSTEMI) is the most common acute coronary syndrome (ACS), often linked with multivessel coronary artery disease (MVD).
  • Patients with NSTEMI and MVD are high-risk due to age, comorbidities, and atherosclerosis.
  • Optimal revascularization strategies for NSTEMI with MVD remain uncertain, unlike in STEMI.

Purpose of the Study:

  • To synthesize contemporary evidence on percutaneous coronary intervention (PCI)-based revascularization strategies in NSTEMI with MVD.
  • To focus on the extent of revascularization (complete vs. incomplete) and timing (single-stage vs. staged).
  • To identify consensus, uncertainties, and evidence gaps in current practice.

Main Methods:

  • Narrative review of contemporary evidence.
  • Integration of findings from registries, randomized trials, and guideline recommendations.
  • Focus on PCI strategies for NSTEMI patients with MVD.

Main Results:

  • Current data suggest complete PCI is associated with reduced recurrent ischemia, reinfarction, and repeat revascularization.
  • Potential long-term survival benefits with complete PCI exist.
  • Patient comorbidities, lesion complexity, and procedural risk influence outcomes, necessitating individualized decision-making.

Conclusions:

  • Complete PCI generally offers better outcomes than culprit-only PCI in NSTEMI with MVD.
  • Individualized treatment decisions are critical due to patient-specific factors.
  • Large, dedicated trials are needed to guide optimal practice and improve outcomes for this high-risk population.